{"id":"https://openalex.org/W15268058","doi":null,"title":"Individual clearance and therapeutic drug monitoring of quetiapine in clinical practice.","display_name":"Individual clearance and therapeutic drug monitoring of quetiapine in clinical practice.","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W15268058","mag":"15268058","pmid":"https://pubmed.ncbi.nlm.nih.gov/20424588"},"language":"en","primary_location":{"id":"pmid:20424588","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20424588","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro endocrinology letters","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047960914","display_name":"Markus Wittmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Markus Wittmann","raw_affiliation_strings":["Department of Psychiatry, Psychosomatics and Psychotherapy, University of Regensburg, Germany. markus.wittmann@medbo.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Psychosomatics and Psychotherapy, University of Regensburg, Germany. markus.wittmann@medbo.de","institution_ids":["https://openalex.org/I60668342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088103051","display_name":"Helmut H. Hausner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helmut Hausner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031335866","display_name":"Anton K\u00f6stlbacher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anton K\u00f6stlbacher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071697628","display_name":"G\u00f6ran Hajak","orcid":"https://orcid.org/0000-0002-8190-0355","observed_orcids":["https://orcid.org/0000-0002-8190-0355"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Goran Hajak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072705250","display_name":"Ekkehard Haen","orcid":"https://orcid.org/0000-0003-4430-4148","observed_orcids":["https://orcid.org/0000-0003-4430-4148"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ekkehard Haen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0494,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.70578532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"31","issue":"2","first_page":"203","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8871999979019165,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8871999979019165,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.07590000331401825,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.9430000185966492},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.7960000038146973},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8270000219345093},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.843999981880188},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7120000123977661},{"id":"https://openalex.org/keywords/trough-concentration","display_name":"trough concentration","score":0.6100000143051147},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5590000152587891},{"id":"https://openalex.org/keywords/age-and-gender-effects","display_name":"age and gender effects","score":0.8709999918937683},{"id":"https://openalex.org/keywords/treatment-nonadherence","display_name":"treatment non-adherence","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.9669029712677002},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.8271844387054443},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5771372318267822},{"id":"https://openalex.org/C2911140283","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine Fumarate","level":5,"score":0.5414884090423584},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.5187047123908997},{"id":"https://openalex.org/C102652120","wikidata":"https://www.wikidata.org/wiki/Q2419430","display_name":"Therapeutic effect","level":2,"score":0.517890214920044},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5162448883056641},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.5139662623405457},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5080876350402832},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.4837055802345276},{"id":"https://openalex.org/C3020081911","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Serum concentration","level":2,"score":0.42794832587242126},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.4115429222583771},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36818891763687134},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.17933958768844604},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.17268720269203186},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.1480650007724762},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.07047584652900696},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.06503134965896606},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:20424588","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20424588","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro endocrinology letters","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W13210705","https://openalex.org/W1586800492","https://openalex.org/W1978470492","https://openalex.org/W2011440681","https://openalex.org/W2016382954","https://openalex.org/W2067916044","https://openalex.org/W2127059331","https://openalex.org/W2153226419","https://openalex.org/W2155268095"],"related_works":["https://openalex.org/W2036020153","https://openalex.org/W2326912580","https://openalex.org/W2327925560","https://openalex.org/W2312652864","https://openalex.org/W2107475180","https://openalex.org/W303035940","https://openalex.org/W2080724513","https://openalex.org/W1984759793","https://openalex.org/W2618758272","https://openalex.org/W4402117719"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Quetiapine":[1,25,83,117],"is":[2,26],"one":[3],"of":[4,15,24,40,51,116,131,175],"the":[5,12,38,46,56,63,124,132,137,144,151,154,159],"most":[6],"frequent":[7],"prescribed":[8],"antipsychotics.":[9],"Based":[10],"on":[11,45],"consensus":[13],"guidelines":[14],"therapeutic":[16,138,152],"drug":[17],"monitoring":[18],"(TDM)":[19],"in":[20,59,70,173],"clinical":[21,81],"practice,":[22],"TDM":[23],"\"useful\".":[27],"In":[28,148],"this":[29],"pilot":[30],"study,":[31],"using":[32,89],"a":[33,104],"natural":[34],"sample,":[35],"we":[36,54],"investigated":[37],"influence":[39],"co-medication,":[41],"age":[42],"and":[43,49,97,113],"gender":[44],"serum":[47,85,114,133],"concentrations":[48],"clearance":[50,58,65,125,156,161],"Quetiapine.":[52],"Also":[53],"compared":[55],"individual":[57,155,166],"our":[60],"sample":[61],"with":[62],"expected":[64,145,160],"for":[66,169],"healthy":[67],"subjects,":[68],"obtained":[69],"controlled":[71],"studies.":[72],"METHODS:":[73],"150":[74],"blood":[75],"samples":[76],"were":[77,87,135,142],"collected":[78],"anonymously":[79],"under":[80],"conditions,":[82],"trough":[84],"levels":[86,115,134],"determined":[88],"HPLC.":[90],"Additional":[91],"information":[92],"about":[93],"gender,":[94],"age,":[95],"co-medication":[96],"dosage":[98],"was":[99,103,122,126],"obtained.":[100],"RESULTS:":[101],"There":[102],"significant,":[105],"positive,":[106],"but":[107],"weak":[108],"correlation":[109],"between":[110],"daily":[111],"dose":[112],"(r=0.44;":[118],"p=0.01).":[119],"When":[120],"Carbamazepine":[121],"co-administered,":[123],"significantly":[127],"higher":[128],"(p=0.01).":[129],"83%":[130],"outside":[136],"range,":[139],"only":[140],"28%":[141],"within":[143],"clearance.":[146],"CONCLUSIONS:":[147],"addition":[149],"to":[150,158,164],"range":[153],"related":[157],"may":[162],"help":[163],"optimize":[165],"pharmacotherapy,":[167],"especially":[168],"combination":[170],"therapy":[171],"or":[172,177],"case":[174],"incompliance":[176],"abnormal":[178],"metabolism.":[179]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}